Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 1, 2015, Pages 91-94

  Alicino, Cristiano ^a,b   Merlano, Caterina ^c   Zappettini, Simona ^c   Schiaffino, Sergio ^d   Della Luna, Giovanni ^d   Accardo, Cristina ^a,b   Gasparini, Roberto ^a   Durando, Paolo ^a,b   Icardi, Giancarlo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Regional Health Agency of Liguria   (Italy)

^d Department of Health and Social Services ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADVERSE EFFECTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMAN; IMMUNIZATION; ITALY; POSTMARKETING SURVEILLANCE; PROCEDURES; PUBLIC HEALTH SERVICE; STATISTICS AND NUMERICAL DATA;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; IMMUNIZATION; INFLUENZA VACCINES; ITALY; PRODUCT SURVEILLANCE, POSTMARKETING; PUBLIC HEALTH ADMINISTRATION;

EID: 84949116446     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.34360     Document Type: Conference Paper

References (12)

1. Duclos P, Okwo-Bele JM, Gacic-Dobo M, Cherian T. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 2009; 9(Suppl 1):S2; PMID:19828060; http://dx.doi.org/10.1186/1472-698X-9-S1-S2
2. Lankinen KS, Pastila S, Kilpi T, Nohynek H, Mäkelä;PH, Olin P. Vaccinovigilance in Europe - need for timeliness, standardization and resources. Bull World Health Organ 2004; 82:828-35; PMID:15640918
3. Bonhoeffer J, Black S, Izurieta H, Zuber P, Sturkenboom M. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe. Biologicals 2012; 40:393-7; PMID:22902972; http://dx.doi.org/10.1016/j.biologicals.2012.07.007
4. Zanoni G, Berra P, Lucchi I, Ferro A, O'Flanagan D, Levy-Bruhl D, Salmaso S, Tridente G. Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts. Vaccine 2009; 27:3376-84; PMID:19200851; http://dx.doi.org/10.1016/j.vaccine.2009.01.059
5. Miller ER, Haber P, Hibbs B, Broder K. Surveillance for Adverse Events Following Immunization Using the Vaccine Adverse Event Reporting System (VAERS). In Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention, Atlanta, GA, 2008.
6. Collet JP, MacDonald N, Cashman N, Pless R; Advisory Committee on Causality Assessment. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Bull World Health Organ 2000; 78:178-85; PMID:10743282
7. Alicino C, Infante MT, Gandoglia I, Miolo N, Mancardi GL, Zappettini S, Capello E, Orsi A, Tamburini T, Grandis M. Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine. Hum Vaccin Immunother 2014; 10:10; PMID:24785431; http://dx.doi.org/10.4161/hv.28961
8. Agenzia Italiana del Farmaco. Report on post-markeing surveillance of vaccines in Italy during 2012. Rome 2013.
9. REGULATION. (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products. Available from https://eudravigilance.ema.europa.eu/human/docs/Regulations/reg-2010-1235-en.pdf.
10. Clothier HJ, Crawford NW, Kempe A, Buttery JP. Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria. Commun Dis Intell Q Rep 2011; 35:294-8; PMID:22624490
11. Micheletti F, Moretti U, Tridente G, Zanoni G. Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008. Hum Vaccin 2011; 7(Suppl):234-9; PMID:21301223; http://dx.doi.org/10.4161/hv.7.0.14613
12. Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, Casey C, Dekker C, Edwards KM, Klein J, et al. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2012; 30:7253-9; PMID:23063829; http://dx.doi.org/10.1016/j.vaccine.2012.09.074